PT - JOURNAL ARTICLE AU - Vincenzo Galasso AU - Paola Profeta AU - Martial Foucault AU - Vincent Pons TI - COVID-19 Vaccine’s Gender Paradox AID - 10.1101/2021.03.26.21254380 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.26.21254380 4099 - http://medrxiv.org/content/early/2021/03/26/2021.03.26.21254380.short 4100 - http://medrxiv.org/content/early/2021/03/26/2021.03.26.21254380.full AB - Women die less than men of COVID-19, but have been more concerned about its health consequences and more compliant with the public health rules imposed during the pandemic. Since return to normal life depends on vaccination, but delays in acceptance or outright refusals of vaccination are already evident, we investigate gender differences in attitudes and expected behaviors regarding COVID-19 vaccination. Using original data from a survey conducted in December 2020 in ten developed countries (N=13,326), we discover a COVID-19 Vaccine’s gender paradox. Being more concerned about COVID-19 and more likely to believe to be infected and consequently to become seriously ill, women could be expected to be more supportive of vaccination than men. Instead, our findings show that women agree less than men to be vaccinated and to make vaccination compulsory. Our evidence suggests that their vaccine hesitance is partly due skepticism, since women are less likely to believe that vaccination is the only solution to COVID-19 and more likely to believe that COVID-19 was created by large corporations. Using a survey experiment performed in these ten countries, we show that information provision on the role of vaccination to become immune to COVID-19 is effective in reducing vaccine hesitance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial Support from ANR (French Agency for Research) - REPEAT grant (Special COVID-19) and Unicredit Foundation are acknowledged.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Committee of Bocconi University deemed the overall research project "REPEAT: Attitude on Covid related measures" SA000085 to be compliant with the Research Ethics Policy of the university.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur survey data are not public for now but the data and codes will be made available on the journal webpage upon publication and Galasso′ Harvard dataverse